Product image of Ibet (Betamethasone Sodium Phosphate) supplied by GNH India

Ibet

Active Ingredient:
Betamethasone Sodium Phosphate
Origin:
EU

Ibet (Betamethasone Sodium Phosphate)

Betamethasone sodium phosphate, the active ingredient in Ibet, is a corticosteroid presented as an injectable solution for intramuscular or intravenous use. It provides anti‑inflammatory and immunosuppressive effects for acute allergic, respiratory and musculoskeletal conditions. It is marketed in the European Union and is indicated for rapid control of severe inflammation.

GNH India supplies Ibet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Manufacturer / TM Owner

Biopharma S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Betamethasone sodium phosphate is used as a glucocorticoid to manage acute inflammatory and immune‑mediated conditions.

  • Severe allergic reactions: rapid reduction of airway edema, hives and systemic inflammation.
  • Acute asthma exacerbations: swift bronchodilation and suppression of airway inflammatory cells.
  • Rheumatic musculoskeletal inflammation: inhibition of cytokine release to relieve joint swelling and pain.
  • Post‑operative edema: control of fluid accumulation and tissue inflammation after surgery.

How It Works

  • Betamethasone sodium phosphate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction up‑regulates anti‑inflammatory proteins such as annexin‑1 and down‑regulates pro‑inflammatory cytokines, chemokines, and adhesion molecules, resulting in reduced leukocyte migration, vascular permeability, and immune activation.

Side Effects

Betamethasone sodium phosphate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Hyperglycemia: elevated blood glucose levels, especially in diabetic patients.
  • Fluid retention: swelling of extremities and weight gain.
  • Mood changes: irritability, insomnia or euphoria.

Serious or Rare Side Effects

  • Adrenal suppression: reduced endogenous cortisol production.
  • Severe infection: increased susceptibility to bacterial, viral or fungal pathogens.
  • Osteonecrosis: bone tissue death, particularly in weight‑bearing joints.
  • Psychosis: hallucinations, severe mood disturbances or delirium.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications.

  • Infection risk: assess for active infections and avoid use in uncontrolled sepsis.
  • Blood glucose: monitor diabetic patients closely for hyperglycaemia.
  • Blood pressure: watch for hypertension or fluid overload.
  • Dose tapering: avoid abrupt discontinuation to prevent adrenal crisis.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Betamethasone sodium phosphate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Systemic CYP3A4 inhibitors: may increase glucocorticoid exposure.
  • Live vaccines: risk of attenuated pathogen replication.
  • Anticoagulants: enhanced bleeding tendency.

Moderate Interactions (Monitor Closely)

  • Diuretics: potential potassium loss and electrolyte imbalance.
  • Antidiabetic agents: may require dose adjustment due to altered glucose control.
  • NSAIDs: increased risk of gastrointestinal ulceration and bleeding.

Frequently Asked Questions

Ibet contains betamethasone sodium phosphate, a potent glucocorticoid used to treat acute severe allergic reactions, asthma exacerbations, and inflammatory musculoskeletal conditions such as rheumatoid arthritis. It is administered by injection to achieve rapid systemic anti‑inflammatory and immunosuppressive effects.

The drug binds to intracellular glucocorticoid receptors, forming a complex that enters the nucleus and alters gene transcription. This up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, reducing leukocyte migration, vascular permeability, and overall immune activation.

Dosing of Ibet is individualized and must be prescribed by a qualified healthcare professional. The prescriber determines the amount, route (intramuscular or intravenous), and frequency based on the specific indication, patient weight, severity of disease, and response to therapy.

The safety of betamethasone sodium phosphate in pregnancy and lactation has not been definitively established. Physicians should weigh potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing patients.

To request Ibet, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Betamethasone sodium phosphate is a high‑potency, short‑acting glucocorticoid, offering faster onset than many oral steroids. Compared with dexamethasone, it has similar anti‑inflammatory strength but is typically given intravenously for rapid control, whereas dexamethasone is often used orally or intramuscularly for longer‑acting effects.

Ibet should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Before use, allow the vial to reach room temperature if required, and inspect for particulate matter or discoloration.

Ibet is supplied as a sterile injectable solution and may be given either intramuscularly or intravenously by a qualified healthcare professional. The route, volume, and rate of injection are determined by the prescribing clinician based on the therapeutic indication.

Serious risks include adrenal suppression, severe infections, osteonecrosis, and psychiatric disturbances such as psychosis. Patients should be monitored for signs of infection, unexplained fatigue, mood changes, or bone pain, and the drug should be tapered gradually to avoid adrenal crisis.

Ibet is contraindicated in patients with known hypersensitivity to betamethasone or any formulation component, uncontrolled systemic infections, and those receiving live vaccines. Caution is also advised for individuals with uncontrolled diabetes, hypertension, or a history of severe psychiatric illness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Betamethasone Sodium Phosphate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT